The Board of Directors of the Foundation for the National Institutes of Health (FNIH), after an extensive search, has named Dr. Scott Campbell as its new executive director and chief executive officer.

The Observational Medical Outcomes Partnership (OMOP) today announced the winners of its OMOP Cup methods competition, which featured two separate challenges designed to help predict associations between therapeutic drugs and medical outcomes (or adverse events). It encouraged participation from researchers of many fields and entities—both public and private.

The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.

The Research Partnership in Cognitive Aging, a public-private effort to promote the study of brain function with age, will award up to $28 million over five years to 17 research grants to examine the neural and behavioral profiles of healthy cognitive aging and explore interventions that may prevent, reduce or reverse cognitive decline in older people.